- 4.4Impact Factor
- 8.8CiteScore
- 21 daysTime to First Decision
Translational Research in Gynecologic Cancer
This special issue belongs to the section “Clinical Research of Cancer“.
Special Issue Information
Dear Colleagues,
Research and treatment in the field of gynecological cancers have dramatically changed with the advent of various molecular-targeted drugs and immune checkpoint inhibitors. The development of these novel therapies was largely due to technological advances in genomic and transcriptomic analysis of cancers and the accumulation of their multi-omics data. Furthermore, single-cell analysis of gynecological cancers is expected to lead to the development of novel therapies based on the analysis of intratumor heterogeneity and stromal cells. This Special Issue aims to collect original papers and innovative review articles detailing translational research on cancer of the uterus, ovary, fallopian tubes, vagina, and vulva.
Please note that reviews and meta-analyses of clinical studies, analyses of epidemiological data, and analyses of public omics data that do not involve the development of novel bioinformatics techniques fall out of scope of this Special Issue.
Prof. Dr. Noriomi Matsumura
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- gynecologic cancer
- translational research
- omics
- molecular target
- immune therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

